21 CFR 870.4260
§ 870.4260 Cardiopulmonary bypass arterial line blood filter.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 870.4260, § 870.4260 Cardiopulmonary bypass arterial line blood filter, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/89994
- Permanent ID
ys:prov:89994@1- SHA-256
55a7fa729ce4976bd7df9c2bf7c3426157c97d8c0bb65a42b8f419e1a5d1835c
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Identification. A cardiopulmonary bypass arterial line blood filter is a device used as part of a gas exchange (oxygenator) system to filter nonbiologic particles and emboli (blood clots or pieces of foreign material flowing in the bloodstream which will obstruct circulation by blocking a vessel) out of the blood. It is used in the arterial return line.
(b) Classification. Class II (special controls). The special control for this device is the FDA guidance document entitled “Guidance for Cardiopulmonary Bypass Arterial Line Blood Filter 510(k) Submissions.”
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.